Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.

Current opinion in urology - 1 May 2014

Donovan Michael J, Cordon-Cardo Carlos

Abstract excerpt

PURPOSE OF REVIEW: For patients newly diagnosed with prostate cancer, the most significant question is whether the 'truly malignant' disease has been identified. This review will provide an overview of current prostate cancer genomic and biomarker discovery - validation strategies geared towards identifying aggressive, clinically significant disease at the time of diagnosis. RECENT FINDINGS: Based on recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Testing
Share to Genomics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Predictive Value of Tests

Share to Prostatic Neoplasms

Share to Risk Assessment

Share to Risk Factors

Share to Systems Biology

Source

Identifiers

PMID: 24625431
DOI: 10.1097/MOU.0000000000000051

Genes

PTEN
TMPRSS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.PMID 24625431Read ↗

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity Read ↗

Future directions for precision oncology in prostate cancerSemantic proximity Read ↗

Prostate cancer – a biomarker perspectiveSemantic proximity Read ↗

Genomic Profiling of Prostate Cancer: An Updated ReviewSemantic proximity Read ↗

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerSemantic proximity Read ↗

The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Liquid biopsy in prostate cancer: A novel dual biomarker analysis approach integrating circulating tumor cells and circulating tumor DNA data.Semantic proximity Read ↗

Prostate cancer genotyping for risk stratification and precision treatmentSemantic proximity Read ↗

Emerging Molecular Biomarkers in Advanced Prostate Cancer: Translation to the Clinic.Semantic proximity Read ↗

Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity Read ↗

The Genomic Landscape of Prostate CancerSemantic proximity Read ↗

Genetics and Screening in Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.